Albemarle to Move cGMP Operations to Michigan Site

Albemarle says it will relocate operations at a pharmaceutical-grade cGMP pilot plant at Dayton, OH to its recently acquired cGMP manufacturing facility at South Haven, MI. The transfer will occur before the end of the second-quarter. The move follows Albemarle’s acquisition last October of DSM’s pharmaceutical chemical business at South Haven (CW, Sept. 27, 2006, p. 9). The deal included the assets, fine chemistry services, and pharmaceutical business associated with the South Haven plant. Financial terms were undisclosed. The consolidation, along...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers